CEFAZOLIN AND DEXTROSE Drug Patent Profile
✉ Email this page to a colleague
When do Cefazolin And Dextrose patents expire, and what generic alternatives are available?
Cefazolin And Dextrose is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in CEFAZOLIN AND DEXTROSE is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefazolin And Dextrose
A generic version of CEFAZOLIN AND DEXTROSE was approved as cefazolin sodium by SANDOZ on December 9th, 1988.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CEFAZOLIN AND DEXTROSE?
- What are the global sales for CEFAZOLIN AND DEXTROSE?
- What is Average Wholesale Price for CEFAZOLIN AND DEXTROSE?
Summary for CEFAZOLIN AND DEXTROSE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Clinical Trials: | 174 |
| Patent Applications: | 4,006 |
| DailyMed Link: | CEFAZOLIN AND DEXTROSE at DailyMed |
Recent Clinical Trials for CEFAZOLIN AND DEXTROSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hamilton Health Sciences Corporation | PHASE4 |
| Asan Medical Center | NA |
| Canadian Institutes of Health Research (CIHR) | PHASE4 |
Pharmacology for CEFAZOLIN AND DEXTROSE
| Drug Class | Cephalosporin Antibacterial |
US Patents and Regulatory Information for CEFAZOLIN AND DEXTROSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-002 | Jul 27, 2000 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-001 | Jul 27, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-003 | Jan 13, 2012 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| B Braun | CEFAZOLIN AND DEXTROSE | cefazolin sodium | INJECTABLE;INJECTION | 050779-004 | Aug 26, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
